Portfolio Alerts Watch List Cart

Healthcare

Refine Search


Product Compare (0)
J
Jenburkt Pharmaceuticals Ltd
Score 68/100• Decent
Jenburkt Pharmaceuticals Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised.
Company’s Health84/100
Valuation 60/100 · PB 2.6978
Technical Avoid
1M -5.23% 6M -3.873% 1Y -3.784%
Confidence100%
Low leverage (D/E)No promoter pledge
#46
View details ➜
T
Trident Lifeline Ltd
Score 68/100• Decent
Trident Lifeline Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Caution is advised.
Company’s Health70/100
Valuation 40/100 · PB 4.8599
Technical Avoid
1M 3.546% 6M 15.575% 1Y 2.474%
Confidence100%
Healthy profit marginsDecent revenue growth
Promoter pledge present
#47
View details ➜
T
Themis Medicare Ltd
Score 68/100• Decent
Themis Medicare Ltd shows potential but faces several challenges that could impact future performance.
Company’s Health73/100
Valuation 60/100 · PB 2.8851
Technical Avoid
1M -6.168% 6M -2.691% 1Y -54.514%
Confidence100%
Low leverage (D/E)Reasonable PB valuation
Weak ROEPromoter pledge present
#48
View details ➜
T
Tatva Chintan Pharma Chem Ltd
Score 68/100• Decent
Tatva Chintan Pharma Chem Ltd shows potential for growth in a favorable sector, but valuation concerns and execution risks should be monitored.
Company’s Health72/100
Valuation 40/100 · PB 4.0419
Technical Momentum
1M 8.286% 6M 79.664% 1Y 27.405%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#49
View details ➜
S
Suven Life Sciences Ltd
Score 68/100• Decent
Suven Life Sciences Ltd shows potential for growth, but faces challenges in valuation and execution risks.
Company’s Health49/100
Valuation 20/100 · PB 41.0256
Technical Avoid
1M -13.916% 6M 55.499% 1Y 44.901%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#50
View details ➜
S
Solara Active Pharma Sciences Ltd
Score 68/100• Decent
Solara Active Pharma Sciences Ltd shows potential for growth, but faces challenges in profitability and market competition.
Company’s Health24/100
Valuation 60/100 · PB 2.3677
Technical Avoid
1M -14.576% 6M 12.038% 1Y -22.529%
Confidence100%
Reasonable PB valuation
Weak ROEPromoter pledge present
#51
View details ➜
S
SMS Pharmaceuticals Ltd
Score 68/100• Decent
SMS Pharmaceuticals Ltd shows decent potential with consistent growth, but faces challenges in valuation and liquidity.
Company’s Health66/100
Valuation 40/100 · PB 4.0377
Technical Avoid
1M -5.468% 6M 30.134% 1Y -21.014%
Confidence100%
Low leverage (D/E)
Weak ROEPromoter pledge present
#52
View details ➜
S
Shukra Pharmaceuticals Ltd
Score 68/100• Decent
Shukra Pharmaceuticals Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised for investors.
Company’s Health89/100
Valuation 20/100 · PB 24.9391
Technical Momentum
1M 21.461% 6M 83.069% 1Y 379.245%
Confidence100%
Low leverage (D/E)No promoter pledge
#53
View details ➜
S
Shelter Pharma Ltd
Score 68/100• Decent
Shelter Pharma Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised.
Company’s Health85/100
Valuation 80/100 · PB 1.3763
Technical Avoid
1M -4.072% 6M 5.902% 1Y -8.717%
Confidence100%
Low leverage (D/E)No promoter pledge
#54
View details ➜
S
Shanmuga Hospital Ltd
Score 68/100• Decent
Shanmuga Hospital Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised.
Company’s Health93/100
Valuation 80/100 · PB 1.5585
Technical Avoid
1M 1.111% 6M 19.323% 1Y -11.404%
Confidence100%
Low leverage (D/E)No promoter pledge
#55
View details ➜
S
Shalby Ltd
Score 68/100• Decent
Shalby Ltd shows potential in a growing sector, but faces challenges in growth consistency and valuation. Caution is advised.
Company’s Health75/100
Valuation 60/100 · PB 2.6387
Technical Watch
1M 9.161% 6M 27.122% 1Y -5.023%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#56
View details ➜
S
Samrat Pharmachem Ltd
Score 68/100• Decent
Samrat Pharmachem Ltd shows potential but faces challenges in growth consistency and valuation. Caution is advised.
Company’s Health75/100
Valuation 80/100 · PB 1.2447
Technical Avoid
1M -9.575% 6M -12.095% 1Y -45.98%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#57
View details ➜
R
Rainbow Children's Medicare Ltd
Score 68/100• Decent
Rainbow Children's Medicare Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health92/100
Valuation 20/100 · PB 9.1058
Technical Avoid
1M -8.58% 6M -15.506% 1Y -9.97%
Confidence100%
No promoter pledgeHealthy profit margins
#58
View details ➜
P
Panacea Biotec Ltd
Score 68/100• Decent
Panacea Biotec Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health55/100
Valuation 40/100 · PB 3.3044
Technical Avoid
1M 4.623% 6M -4.712% 1Y 38.885%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#59
View details ➜
M
Mankind Pharma Ltd
Score 68/100• Decent
Mankind Pharma Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
Company’s Health97/100
Valuation 20/100 · PB 6.9294
Technical Avoid
1M -4.947% 6M 0.808% 1Y -10.978%
Confidence100%
No promoter pledgeHealthy profit margins
#60
View details ➜
Showing 46 to 60 of 301 (21 Pages)